MUMBAI, Feb 23 (Reuters) - U.S. and EU drug regulators called upon India's pharmaceutical sector on Tuesday to step up efforts to improve manufacturing standards and ensure the reliability of data if it is to maintain its dominance in the generic drugs industry.
Read more
No comments:
Post a Comment